| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 08/08/2007 | CN1330632C 2,5-substituted benzoluslfonylureas and thioureas, methods for production thereof, use thereof and pharamceutical preparations containing the same |
| 08/08/2007 | CN1330622C Production of alkenones |
| 08/08/2007 | CN101014581A Novel piperidine derivative for the treatment of depression |
| 08/08/2007 | CN101014572A Carbamoylpyridone derivative having HIV integrase inhibitory activity |
| 08/08/2007 | CN101014565A Diarylsulfones as 5-HT2a antagonists |
| 08/08/2007 | CN101014564A Substituted acids for the treatment of respiratory diseases |
| 08/08/2007 | CN101014328A Novel biaromatic compounds which activate receptors of PPAR type and their use in cosmetic or pharmaceutical compositions |
| 08/08/2007 | CN101012194A Method for preparing 2,3,5-trimethylpyridine |
| 08/07/2007 | US7253297 Astaxanthin esters |
| 08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 08/07/2007 | US7253211 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity |
| 08/07/2007 | US7253194 Compounds and inhibitors of phospholipases |
| 08/07/2007 | US7253193 Pyridyl cyanoguanidine compounds, e.g., 1-[2-(4-Piperidyl)-ethoxy-carbonyloxymethyl]-4-[N'-cyano-N''-(6-(4-chloro-phenoxy)-1-hexyl)-N-guanidino]-pyridinium chloride, hydrochloride; human and veterinary therapy of proliferative diseases such as cancers |
| 08/07/2007 | US7253192 Phenyl derivatives comprising an acetylene group |
| 08/07/2007 | US7253189 1-aminoindane derivatives, e.g., 1-(cyclopentylcarbonylamino)-5-(4-cyclopropyl-2-(phenylsulfonyl)phenylsulfonyl)indane; exhibit anti-inflammatory and immunomodulatory activity |
| 08/07/2007 | US7253178 Carboxylic acids |
| 08/07/2007 | US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 08/07/2007 | US7253173 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents |
| 08/07/2007 | US7253168 Substituted 1-benzyl-4-substituted piperazine analogues |
| 08/07/2007 | US7253157 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes. |
| 08/07/2007 | CA2221689C Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions |
| 08/07/2007 | CA2190256C Process for preparing aromatic or heteroaromatic sulfonyl halides |
| 08/02/2007 | WO2007087585A1 Piperazinyl derivatives as modulators of chemokine receptor activity |
| 08/02/2007 | WO2007087135A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS |
| 08/02/2007 | WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K |
| 08/02/2007 | WO2007086552A1 Novel compound and organic electroluminescent device using same |
| 08/02/2007 | WO2007086505A1 Transition metal complex compound and organic electroluminescent device using same |
| 08/02/2007 | WO2007085898A2 Improved chemical identification of peroxide-based explosives |
| 08/02/2007 | WO2007085750A1 Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 08/02/2007 | WO2007063702A3 Iminopropene compound and use thereof |
| 08/02/2007 | WO2007056151A3 Protein kinase inhbitors |
| 08/02/2007 | WO2006073361A9 Novel pyridine compounds |
| 08/02/2007 | WO2006037501A9 Alkil-pyridines as 11-beta inhibitors for diabetes |
| 08/02/2007 | US20070179192 Thrombopoietin mimetics |
| 08/02/2007 | US20070179183 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 08/02/2007 | US20070179165 Cyclic compounds |
| 08/02/2007 | US20070179162 Triazolopyrimdines |
| 08/02/2007 | US20070179143 Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 08/02/2007 | US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 08/02/2007 | US20070179139 Methyl 4-{[(2-{4-[(4-bromophenoxy)methyl]-2,5-dimethyl-3-thienyl}ethyl)(5-ethoxy-5-oxopentyl)amino]methyl}benzoate, for example; treatment of cardiovascular and other diseases |
| 08/02/2007 | US20070179120 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 08/02/2007 | US20070178134 Pyridines and uses thereof |
| 08/02/2007 | US20070176164 -Conjugated aromatic ring-containing compound and organic electroluminescent device |
| 08/02/2007 | CA2640091A1 Vinyl-phenyl derivatives for inflammation and immune-related uses |
| 08/02/2007 | CA2636931A1 Piperazines and piperidines as mglur5 potentiators |
| 08/02/2007 | CA2607576A1 Improved chemical identification of peroxide-based explosives |
| 08/01/2007 | EP1813621A1 Ruthenium complex and process for producing tert-alkyl alcohol therewith |
| 08/01/2007 | EP1813284A1 Pharmaceutical composition |
| 08/01/2007 | EP1813270A1 Hsp90 family protein inhibitors |
| 08/01/2007 | EP1812392A1 Process for preparation of isonicotinic acid derivatives |
| 08/01/2007 | EP1812383A1 Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof |
| 08/01/2007 | EP1812363A1 Selective oxidation of organic compounds |
| 08/01/2007 | EP1507760B1 Cyanoguanidine prodrugs |
| 08/01/2007 | EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/01/2007 | EP1373194B1 BENZAMIDE INHIBITORS OF FACTOR Xa |
| 08/01/2007 | EP1187592B1 Alpha v integrin receptor antagonists |
| 08/01/2007 | CN1329389C Novel compounds and their use |
| 08/01/2007 | CN1329386C Substituted phenylacetamides and their use as glucokinase activators |
| 08/01/2007 | CN1329375C Novel anti-diabetic agents |
| 08/01/2007 | CN101010300A 2-phenylpyridine derivative |
| 08/01/2007 | CN101010299A Six-membered heterocycles useful as serine protease inhibitors |
| 08/01/2007 | CN101010298A Histone deacetylase inhibitor prodrugs |
| 08/01/2007 | CN101010291A Method for the production of tricyanomethanides of organic cations |
| 08/01/2007 | CN101010276A Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 08/01/2007 | CN101007805A 6-cyano-1,1-disubstituted alkoxy(alkylsulphide)-7-[(carbalkoxy)-methyl]-5-oxo-delta6(8)-tetrahydro indolizine compound preparation method |
| 08/01/2007 | CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/31/2007 | USRE39754 Benzamide derivatives and pharmaceutical compositions containing same |
| 07/31/2007 | US7250525 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 07/31/2007 | US7250518 treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic bronchitis, and chronic obstructuive pulmonary disease |
| 07/31/2007 | US7250428 Cetylpyridinium diclofenac and its preparation by reacting a mineral or organic salt of diclofenac with cetylpyridinium halide or hydroxide in a solvent such as methylene chloride, chloroform, carbon tetrachloride, dichloroethane, trichloroethane, tetrachloroethane, trichloroethylene and trichloropropane |
| 07/31/2007 | US7250424 Fab I inhibitors |
| 07/31/2007 | CA2403114C Mass labels |
| 07/26/2007 | WO2007083239A1 Pyridine derivatives as sodium channel modulators |
| 07/26/2007 | WO2007083090A2 Process for the preparation of uracil derivatives |
| 07/26/2007 | WO2007082876A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 07/26/2007 | WO2007082840A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| 07/26/2007 | WO2007061360A3 Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides |
| 07/26/2007 | WO2006065706A9 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 07/26/2007 | WO2006056462A9 Azine compounds for combating animal pests |
| 07/26/2007 | US20070173649 Processes for the facile synthesis of diaryl amines and analogues thereof |
| 07/26/2007 | US20070173641 Azotization of 5-amino-3-t-butyl-4-cyanopyrazole, then reacting with couplers and alkylation or arylation, to form azo dyes, used as inks having colorfastness; liquid crystal displays and plasma display panels; excellent color reproducibility |
| 07/26/2007 | US20070173534 Pyridinic sulfonamide derivatives method of production and use thereof |
| 07/26/2007 | US20070173498 Melanin concentrating hormone antagonist |
| 07/26/2007 | CA2637449A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| 07/26/2007 | CA2633329A1 Pyridine derivatives as sodium channel modulators |
| 07/26/2007 | CA2631874A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 07/25/2007 | EP1810970A1 Therapeutic piperazine compounds |
| 07/25/2007 | EP1810965A1 Hydrazide derivatives |
| 07/25/2007 | EP1809619A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| 07/25/2007 | EP1809600A2 Cyclic b-amino acid derivatives as factor xa inhibitors |
| 07/25/2007 | EP1809597A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 07/25/2007 | EP1809284A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/25/2007 | EP1390340A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2007 | EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands |
| 07/25/2007 | EP1005465B1 New epothilone derivatives, method for producing same and their pharmaceutical use |
| 07/25/2007 | CN1328262C Binuclear nickel-series olefine oligomerization catalyst, and its preparation method and use |
| 07/25/2007 | CN1328261C Uracil compounds and their use |
| 07/25/2007 | CN1328247C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |